Expression of Th1/2/17 Cytokines in CML with or without Pulmonary Bacterial and Fungal Coinfection

BACKGROUND: Tyrosine kinase inhibitors (TKIs) are the standard therapy for patients with chronic myeloid leukemia (CML). While their use greatly increases patient survival rates and can lead to normal life expectancy, bacterial infections in the lungs continue to play a significant role in determini...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Xin, Zhang, Chaoran, Hu, Peng, Yang, Zefeng, Zhang, Jinping, Zou, Yunlian, Wen, Yan, Li, Huiyuan, Yang, Tonghua, Zhao, Renbin, Li, Zengzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129429/
https://www.ncbi.nlm.nih.gov/pubmed/37114211
http://dx.doi.org/10.1155/2023/6318548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129429/
https://www.ncbi.nlm.nih.gov/pubmed/37114211
http://dx.doi.org/10.1155/2023/6318548

Ejemplares similares